Pion's FLUX technology combines traditional dissolution testing with repeatable methods for assessing the absorption potential of APIs, API/ingredient combinations or finished dosage products. The result is a single combined test that makes in vitro-in vivo correlation (IVIVC) modeling and bioequivalence testing more realistic - and more reliable.
With Pion FLUX, any problems with the permeability and absorption potential of a promising compound can be identified far earlier in the development process. This saves time and means you can bring new drugs to market more swiftly.
Work with our Analytical Services team, and we can run all the in-vitro tests and assays you need in the Formulation stage of drug development.
With Pion’s MacroFLUX™ device, you can reliably test and rank the absorption potential of formulations in-vitro to greatly enhance in-vivo prediction.
Pion’s BioFLUX™ accurately assesses the absorption potential of finished dosage forms under biorelevant conditions, greatly enhancing IVIVC modelling.